Effects of GnRH immunization in sexually mature pony stallions

• Published in: Animal reproduction science Vol. 86; no. 3; pp. 247 - 259
• Main Authors: Turkstra, J.A., van der Meer, F.J.U.M., Knaap, J., Rottier, P.J.M., Teerds, K.J., Colenbrander, B., Meloen, R.H.
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier B.V 01.04.2005
• Subjects: Animals; Antibodies - blood; Contraception, Immunologic - methods; Contraception, Immunologic - veterinary; drug adjuvants; GnRH immunization; gonadotropin-releasing hormone; Gonadotropin-Releasing Hormone - immunology; Gonadotropin-Releasing Hormone - physiology; Horse stallions; Horses; immune response; immunization; Immunization - veterinary; Male; male fertility; Orchiectomy - veterinary; ovalbumin; Ovalbumin - immunology; semen; seminiferous tubules; Seminiferous Tubules - anatomy & histology; Sexual Behavior, Animal; Shetland pony (horse breed); Sperm Count; Sperm Motility; spermatogenesis; stallions; Testis - anatomy & histology; Testis function; Testosterone; Testosterone - blood; Vaccines, Contraceptive - immunology; Horse stallions; Testosterone; GnRH immunization; Testis function
• ISSN: 0378-4320; 1873-2232
• DOI: 10.1016/j.anireprosci.2004.07.010

Immunization against gonadotrophin releasing hormone (GnRH) was studied as an alternative for the commonly used surgical castration in stallions. Two GnRH vaccines comprising non-mineral oil adjuvants were evaluated for their potential to induce high antibody titers directed against GnRH and subsequent effects on reproductive characteristics. Twelve sexually mature male hemicastrated Shetland ponies were assigned to three groups. Group 1 and 2 were injected with 1 mg peptide equivalent of G6k-GnRH-tandem-dimer conjugated to ovalbumin (OVA) in CoVaccine™ HT adjuvant (GnRH/CoVaccine) and in Carbopol (GnRH/Carbopol), respectively, and group 3 was injected with CoVaccine™ HT adjuvant without antigen (controls). After immunization no adverse effects were observed with respect to the injections sites or general health. Two weeks after the second vaccination antibody titers against GnRH increased rapidly in all animals of the GnRH/CoVaccine group, at the same time reducing serum testosterone levels maximally for the further duration of the experiment. In the GnRH/Carbopol group antibody responses and effects on testosterone levels were intermediate in two stallions and not apparent in the remaining stallions of this group. Semen evaluation showed that from 2 weeks after the second immunization onwards, sperm motility was affected in all stallions treated with GnRH/CoVaccine and one stallion treated with GnRH/Carbopol. Seven weeks after the second immunization, no semen could be collected from two stallions, one of each group, due to suppressed libido. Histological examination of the testes, 15 weeks after the initial immunization, demonstrated reduction in seminiferous tubuli diameters in all stallions of the GnRH/CoVaccine group and one stallion of the GnRH/Carbopol group. Furthermore, spermatogenesis was extremely disorganized in these stallions, as indicated by absence of the lumen in the seminiferous tubules, the absence of spermatozoa and spermatids in the tubular cross-sections and the impossibility to determine the stage of the tubular cross-sections. Testis size was also substantially reduced in three out of four stallions treated with GnRH/CoVaccine. The results demonstrate that two immunizations with G6k-GnRH-tandem-dimer-OVA conjugate in a suitable adjuvant such as CoVaccine™ HT caused a rapid and complete reduction of serum testosterone levels in sexually mature stallions, subsequently leading to reduced sperm motility and affected testis function, while no adverse reactions were observed after immunizations.